Benjamin F. Edwards & Company’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $470K | Sell |
4,780
-165
| -3% | -$16.8K | 0.01% | 706 |
|
|
2024
Q1 | $553K | Buy |
4,945
+167
| +3% | +$18K | 0.01% | 640 |
|
|
2023
Q4 | $482K | Buy |
4,778
+3,302
| +224% | +$328K | 0.01% | 641 |
|
|
2023
Q3 | $128K | Hold |
1,476
| – | – | ﹤0.01% | 830 |
|
|
2023
Q2 | $140K | Sell |
1,476
-600
| -29% | -$50.7K | 0.01% | 807 |
|
|
2023
Q1 | $157K | Sell |
2,076
-3,932
| -65% | -$297K | 0.01% | 781 |
|
|
2022
Q4 | $462K | Buy |
6,008
+3,367
| +127% | +$256K | 0.02% | 477 |
|
|
2022
Q3 | $176K | Buy |
2,641
+400
| +18% | +$25.4K | 0.01% | 709 |
|
|
2022
Q2 | $117K | Buy |
2,241
+1,200
| +115% | +$68.2K | 0.01% | 816 |
|
|
2022
Q1 | $59K | Buy |
1,041
+200
| +24% | +$10.7K | ﹤0.01% | 978 |
|
|
2021
Q4 | $43K | Sell |
841
-91
| -10% | -$4.46K | ﹤0.01% | 1083 |
|
|
2021
Q3 | $46K | Buy |
932
+82
| +10% | +$4.45K | ﹤0.01% | 1045 |
|
|
2021
Q2 | $49K | Sell |
850
-1,615
| -66% | -$94.4K | ﹤0.01% | 1018 |
|
|
2021
Q1 | $150K | Sell |
2,465
-2,404
| -49% | -$133K | 0.01% | 750 |
|
|
2020
Q4 | $261K | Sell |
4,869
-2,434
| -33% | -$126K | 0.02% | 569 |
|
|
2020
Q3 | $343K | Buy |
7,303
+251
| +4% | +$12.9K | 0.02% | 475 |
|
|
2020
Q2 | $368K | Buy |
7,052
+68
| +1% | +$3.5K | 0.03% | 434 |
|
|
2020
Q1 | $335K | Buy |
6,984
+240
| +4% | +$12.5K | 0.03% | 397 |
|
|
2019
Q4 | $341K | Buy |
6,744
+1,590
| +31% | +$82.1K | 0.02% | 473 |
|
|
2019
Q3 | $243K | Buy |
5,154
+2,216
| +75% | +$101K | 0.02% | 518 |
|
|
2019
Q2 | $138K | Buy |
2,938
+1,038
| +55% | +$47.9K | 0.01% | 619 |
|
|
2019
Q1 | $91K | Sell |
1,900
-150
| -7% | -$7.51K | 0.01% | 713 |
|
|
2018
Q4 | $91K | Sell |
2,050
-700
| -25% | -$36.5K | 0.01% | 686 |
|
|
2018
Q3 | $149K | Hold |
2,750
| – | – | 0.01% | 581 |
|
|
2018
Q2 | $134K | Sell |
2,750
-900
| -25% | -$51K | 0.01% | 597 |
|
|
2018
Q1 | $229K | Sell |
3,650
-1,716
| -32% | -$118K | 0.02% | 471 |
|
|
2017
Q4 | $329K | Buy |
5,366
+638
| +13% | +$39.4K | 0.03% | 379 |
|
|
2017
Q3 | $316K | Buy |
4,728
+814
| +21% | +$57.5K | 0.04% | 351 |
|
|
2017
Q2 | $305K | Sell |
3,914
-226
| -5% | -$17.1K | 0.04% | 348 |
|
|
2017
Q1 | $338K | Sell |
4,140
-375
| -8% | -$29.5K | 0.05% | 319 |
|
|
2016
Q4 | $325K | Buy |
4,515
+550
| +14% | +$39.8K | 0.05% | 296 |
|
|
2016
Q3 | $308K | Sell |
3,965
-300
| -7% | -$24.2K | 0.05% | 283 |
|
|
2016
Q2 | $333K | Buy |
4,265
+26
| +0.6% | +$2.07K | 0.06% | 259 |
|
|
2016
Q1 | $347K | Buy |
4,239
+350
| +9% | +$28.5K | 0.07% | 242 |
|
|
2015
Q4 | $347K | Sell |
3,889
-34
| -0.9% | -$2.89K | 0.07% | 234 |
|
|
2015
Q3 | $301K | Buy |
3,923
+197
| +5% | +$16.5K | 0.07% | 257 |
|
|
2015
Q2 | $312K | Buy |
3,726
+165
| +5% | +$14.6K | 0.06% | 275 |
|
|
2015
Q1 | $321K | Buy |
3,561
+125
| +4% | +$10.8K | 0.07% | 264 |
|
|
2014
Q4 | $277K | Hold |
3,436
| – | – | 0.06% | 264 |
|
|
2014
Q3 | $257K | Hold |
3,436
| – | – | 0.06% | 274 |
|
|
2014
Q2 | $236K | Sell |
3,436
-585
| -15% | -$39.8K | 0.06% | 278 |
|
|
2014
Q1 | $281K | Buy |
4,021
+3,126
| +349% | +$217K | 0.08% | 230 |
|
|
2013
Q4 | $60K | Sell |
895
-285
| -24% | -$17.4K | 0.02% | 407 |
|
|
2013
Q3 | $62K | Hold |
1,180
| – | – | 0.02% | 374 |
|
|
2013
Q2 | $56K | Buy |
+1,180
| New | +$53.9K | 0.02% | 353 |
|
Other funds holding CAH
Benjamin F. Edwards & Company's CAH Position: Q2 2024 in Review
Benjamin F. Edwards & Company reduced its Cardinal Health (CAH) stake by 3.3% in Q2 2024, selling an estimated $16.8K and leaving 4,780 shares worth $470K. The position accounts for 0.01% of the portfolio, ranked #706.
Benjamin F. Edwards & Company first reported a position in CAH in Q2 2013 and has held it in 45 quarters since. The position peaked at $553K in Q1 2024. 1,010 funds tracked by Wall St. Rank hold CAH as of Q2 2024.
- Benjamin F. Edwards & Company held 4,780 shares of Cardinal Health worth $470K as of Q2 2024.
- Benjamin F. Edwards & Company sold 165 Cardinal Health shares in Q2 2024, an estimated $16.8K.
- Cardinal Health made up 0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #706 holding.
- Benjamin F. Edwards & Company first reported a position in Cardinal Health in Q2 2013 and has held it in 45 quarters since.
- Benjamin F. Edwards & Company's Cardinal Health position peaked at $553K in Q1 2024.
- 1,010 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2024.
Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.